loading
Schlusskurs vom Vortag:
$76.09
Offen:
$74.7
24-Stunden-Volumen:
97,369
Relative Volume:
0.06
Marktkapitalisierung:
$8.13B
Einnahmen:
$628.56M
Nettoeinkommen (Verlust:
$141.82M
KGV:
60.75
EPS:
1.26
Netto-Cashflow:
$142.60M
1W Leistung:
+1.97%
1M Leistung:
+10.52%
6M Leistung:
+33.06%
1J Leistung:
+175.00%
1-Tages-Spanne:
Value
$74.55
$76.84
1-Wochen-Bereich:
Value
$73.36
$77.02
52-Wochen-Spanne:
Value
$27.30
$117.33

Corcept Therapeutics Inc Stock (CORT) Company Profile

Name
Firmenname
Corcept Therapeutics Inc
Name
Telefon
650.688.8803
Name
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Name
Mitarbeiter
500
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-17
Name
Neueste SEC-Einreichungen
Name
CORT's Discussions on Twitter

Vergleichen Sie CORT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CORT
Corcept Therapeutics Inc
76.65 7.78B 628.56M 141.82M 142.60M 1.26
Biotechnology icon
ONC
Beigene Ltd Adr
241.70 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.08 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.33 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.04 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.45 5.92B 0 -153.72M -103.81M -2.00

Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-06 Hochstufung Truist Hold → Buy
2023-04-11 Eingeleitet SVB Securities Market Perform
2023-04-04 Eingeleitet Piper Sandler Overweight
2023-02-15 Herabstufung Jefferies Buy → Hold
2022-08-01 Herabstufung Truist Buy → Hold
2022-07-27 Hochstufung Jefferies Hold → Buy
2022-06-27 Fortgesetzt Canaccord Genuity Buy
2022-02-02 Eingeleitet Canaccord Genuity Buy
2022-01-28 Eingeleitet Truist Buy
2020-08-05 Herabstufung Jefferies Buy → Hold
2019-09-24 Eingeleitet Jefferies Buy
2019-09-06 Eingeleitet H.C. Wainwright Buy
2019-02-04 Herabstufung B. Riley FBR Buy → Neutral
2018-08-10 Bestätigt Stifel Hold
2018-05-31 Herabstufung Stifel Buy → Hold
2018-03-09 Eingeleitet B. Riley FBR, Inc. Buy
2017-08-31 Eingeleitet Stifel Buy
2017-02-02 Eingeleitet Ladenburg Thalmann Buy
2015-04-21 Eingeleitet FBR Capital Outperform
2014-01-13 Herabstufung Stifel Buy → Hold
2013-08-09 Herabstufung Janney Buy → Neutral
2013-08-09 Herabstufung Ladenburg Thalmann Buy → Neutral
2012-02-21 Bestätigt JMP Securities Mkt Outperform
2010-01-06 Hochstufung Ladenburg Thalmann Neutral → Buy
2008-07-17 Eingeleitet Rodman & Renshaw Mkt Outperform
2007-06-21 Hochstufung Punk, Ziegel & Co Mkt Perform → Accumulate
Alle ansehen

Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten

pulisher
May 22, 2025

Abortion Drugs Market Deep Research and Growth in Future Scope - openPR.com

May 22, 2025
pulisher
May 21, 2025

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT) - FinancialContent

May 21, 2025
pulisher
May 21, 2025

Deutsche Bank AG Buys 24,051 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

May 21, 2025
pulisher
May 19, 2025

CORT Q1 Earnings Call: Pharmacy Disruptions Overshadow Prescription Growth, Guidance Reaffirmed - Yahoo Finance

May 19, 2025
pulisher
May 18, 2025

Critical Review: Kaya (OTCMKTS:KAYS) vs. Corcept Therapeutics (NASDAQ:CORT) - Defense World

May 18, 2025
pulisher
May 15, 2025

Cushing's Disease Market Poised for Significant Growth Across the 7MM During the Study Period (2020-2034) with Rising Awareness and Diagnostic Improvements | DelveInsight - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Cushing's Syndrome Market Growth Drivers and Industry Insights - openPR.com

May 15, 2025
pulisher
May 14, 2025

Corcept Therapeutics (NASDAQ:CORT) Downgraded to “Hold” Rating by StockNews.com - Defense World

May 14, 2025
pulisher
May 12, 2025

Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years - Benzinga

May 12, 2025
pulisher
May 12, 2025

Corcept Therapeutics (NASDAQ:CORT) Is Posting Promising Earnings But The Good News Doesn’t Stop There - Yahoo Finance

May 12, 2025
pulisher
May 11, 2025

Why Corcept Therapeutics (CORT) Is Among the Best Performing Healthcare Stocks to Buy Now - Insider Monkey

May 11, 2025
pulisher
May 10, 2025

11 Best Performing Healthcare Stocks to Buy Now - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Investor Network: Corcept Therapeutics Incorporated. to Host Earnings Call - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

HC Wainwright Has Pessimistic Outlook of CORT Q2 Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Analysts Set Corcept Therapeutics Incorporated (NASDAQ:CORT) Price Target at $143.25 - Defense World

May 09, 2025
pulisher
May 09, 2025

Corcept Therapeutics chief development officer sells $524,652 in stock By Investing.com - Investing.com India

May 09, 2025
pulisher
May 09, 2025

Corcept Therapeutics chief development officer sells $524,652 in stock - Investing.com Australia

May 09, 2025
pulisher
May 08, 2025

Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT) - GuruFocus

May 08, 2025
pulisher
May 08, 2025

High- and Low-Grade Serous Ovarian Cancer Market is Predicted to Grow at a CAGR of 7.9% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.

May 08, 2025
pulisher
May 08, 2025

HC Wainwright Has Lowered Expectations for Corcept Therapeutics (NASDAQ:CORT) Stock Price - Defense World

May 08, 2025
pulisher
May 08, 2025

Corcept Therapeutics (NASDAQ:CORT) Raised to Buy at StockNews.com - Defense World

May 08, 2025
pulisher
May 08, 2025

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 07, 2025

CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares Fall - MSN

May 07, 2025
pulisher
May 07, 2025

Corcept Therapeutics price target lowered to $135 from $150 at Truist - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Corcept Therapeutics (NASDAQ:CORT) Shares Gap Down on Insider Selling - Defense World

May 07, 2025
pulisher
May 06, 2025

Corcept Therapeutics (NasdaqCM:CORT) Reports US$21M Q1 Net Income Lowers EPS - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics (CORT) Faces Price Target Cut Amid Revenue Concerns | CORT Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Assessing Corcept Therapeutics: Insights From 9 Financial Analysts - Benzinga

May 06, 2025
pulisher
May 06, 2025

Truist Cuts Price Target on Corcept Therapeutics to $135 From $150, Keeps Buy Rating - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

H.C. Wainwright cuts Corcept Therapeutics target to $145 By Investing.com - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics (CORT) Receives Revised Price Target from A - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics (CORT) Receives Revised Price Target from Analyst | CORT Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics (CORT) Maintains Buy Rating Amid Revised Pr - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics (CORT) Maintains Buy Rating Amid Revised Price Target | CORT Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics Inc Q1 2025 Earnings: EPS of $0.17 Beats Es - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS A - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics (CORT) Pre-Earnings Options Activity Sugges - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics (CORT) Anticipates Future Growth Amid Reven - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Corcept Therapeutics Inc (CORT) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Decoding Corcept Therapeutics Inc (CORT): A Strategic SWOT Insig - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Corcept Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 05, 2025
pulisher
May 05, 2025

Corcept Therapeutics Stock Jumps On Record Prescription Volume: Retail Sentiment Soars - MSN

May 05, 2025
pulisher
May 05, 2025

Corcept: Q1 Earnings Snapshot - MySA

May 05, 2025
pulisher
May 05, 2025

Corcept Therapeutics (CORT) Set to Announce Q1 Earnings - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Earnings call transcript: Corcept Therapeutics Q1 2025 earnings beat expectations By Investing.com - Investing.com UK

May 05, 2025
pulisher
May 05, 2025

Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

Corcept (NASDAQ:CORT) Misses Q1 Sales Targets, Stock Drops - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

Corcept Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2025
pulisher
May 05, 2025

CORCEPT THERAPEUTICS Earnings Results: $CORT Reports Quarterly Earnings - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Corcept Therapeutics Q1 Earnings Decrease, Revenue Rises -- Shares Fall After Hours - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Corcept Therapeutics (CORT) Reports Q1 Revenue Miss | CORT Stock News - GuruFocus

May 05, 2025

Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.19
price down icon 13.67%
$31.50
price down icon 3.35%
$578.71
price down icon 0.54%
$285.24
price down icon 1.09%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
Kapitalisierung:     |  Volumen (24h):